Boston Scientific's new CEO takes the reins
November 1, 2012 by MassDevice staff
Michael Mahoney can finally remove the "incoming" from his title as he officially takes over the corner office at medical device company Boston Scientific.
Boston Scientific (NYSE:BSX) officially handed the corner office over to Michael Mahoney today, marking the end of a year-long "transition period" for the new CEO.
The day came without fanfare for the medical device company, with a veritable media freeze on the new head man as he embarks on what is likely to be a busy 1st day at the helm.
Mahoney, 47, has spent just over a year at Boston Scientific as president, after being recruited from rival device maker Johnson & Johnson's (NYSE:JNJ) diagnostics and devices group.
Sign up to get our free newsletters delivered right to your inbox.
Late last year Boston Scientific announced Mahoney as the successor to former CEO J. Raymond Elliott, who manned the corner office for 2 years before announcing his retirement in May 2011. Elliott officially retired in October 2011, the day Mahoney joined the company.
"Really, the opportunity was too good to pass up," Mahoney told MassDevice.com about the decision to accept the job at Boston Scientific.
- Show full page
- Login to post comments
-
Permalink
RECENT BLOG POSTS
- A cure for coffee breath?
- A Goldilocks approach to leaky blood vessels: Not too stiff, but not too loose
- Optimizing electronic medication administration records
- A bold new vision for Meditech
- Medtech storytelling in the era of comparative effectiveness
- Medical device sales: Wright Medical's pilot program on rep-less sales process worth watching
- Raising an early warning in the ICU: T3
- Staff shakeup underway at Russian medical device regulator
- Heart Rhythm Society 2013 Scientific Session wrap-up
- Physician blogger insights on social media
Navigation
NEWS
Pluristem launches Phase I clinical trial to treat tendonitis with stem cells
Pluristem is seeking clinical proof that stem cell therapy can benefit patients with chronic...
GE Healthcare unveils soft tissue imaging technology
GE Healthcare introduces Mavric SL, a novel magnetic resonance imaging technique for joint...
Hip implants: Johnson & Johnson's DePuy will stop selling metal-on-metal implants
Johnson & Johnson subsidiary DePuy Orthopaedics plans to phase out sales of all of its metal-on-...
Combat Medical Systems wins 1st-of-its kind approval for tourniquet
The FDA approves a novel combat-ready clamp to treat wounds most commonly associated with roadside or...
Vascular Solutions CEO: Boston Scientific's alleged patent infringement 'blatant'
Vascular Solutions CEO Howard Root says alleged infringement by Boston Scientific's Guidezilla "is...
